Simplex Trading
GENE

Simplex Trading’s Genetic Technologies Ltd. GENE Stock Holding History

Simplex Trading’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-255
Closed – – 9935
2024
Q2 		$0 Buy
+255
New +$574 ﹤0.01% 10132
2024
Q1 		– Sell
-18
Closed – – 10225
2023
Q4 		$0 Buy
+18
New +$60 ﹤0.01% 10133
2023
Q3 		– Sell
-131
Closed -$534 – 10160
2023
Q2 		$0 Buy
131
+89
+212% +$441 ﹤0.01% 10230
2023
Q1 		$0 Buy
+42
New +$246 ﹤0.01% 10438
2022
Q4 		– Sell
-91
Closed -$516 – 10768
2022
Q3 		$0 Buy
+91
New +$664 ﹤0.01% 11146
2022
Q2 		– Sell
-357
Closed -$2.58K – 11408
2022
Q1 		$3K Sell
357
-2,008
-85% -$19.5K ﹤0.01% 9768
2021
Q4 		$22K Sell
2,365
-2,654
-53% -$34K ﹤0.01% 8277
2021
Q3 		$107K Sell
5,019
-13
-0.3% -$223 ﹤0.01% 6530
2021
Q2 		$106K Sell
5,032
-354
-7% -$7.14K ﹤0.01% 6649
2021
Q1 		$112K Buy
5,386
+1,813
+51% +$41.5K ﹤0.01% 5598
2020
Q4 		$64K Buy
3,573
+2,516
+238% +$41.6K ﹤0.01% 5916
2020
Q3 		$18K Buy
+1,057
New +$19.7K ﹤0.01% 6436
2018
Q3 		– Sell
-29
Closed -$659 – 8233
2018
Q2 		$0 Sell
29
-55
-65% -$1.3K ﹤0.01% 8012
2018
Q1 		$1K Buy
84
+59
+236% +$1.71K ﹤0.01% 5851
2017
Q4 		$0 Buy
+25
New +$470 ﹤0.01% 6870
2017
Q2 		– Sell
-216
Closed -$4.53K – 6952
2017
Q1 		$5K Buy
216
+168
+350% +$3.83K ﹤0.01% 4643
2016
Q4 		$1K Buy
+48
New +$1.33K ﹤0.01% 5564
2016
Q2 		– Sell
-1
Closed – – 6600
2016
Q1 		$0 Sell
1
-17
-94% -$740 ﹤0.01% 6408
2015
Q4 		$0 Buy
+18
New +$908 ﹤0.01% 6310

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return

Simplex Trading's GENE Position: Q3 2024 in Review

Simplex Trading sold out of Genetic Technologies Ltd. (GENE) in Q3 2024, closing a stake of 255 shares.

Simplex Trading first reported a position in GENE in Q4 2015 and held it in 19 quarters. The position peaked at $112K in Q1 2021. 10 funds tracked by Wall St. Rank hold GENE as of Q3 2024.

  • Simplex Trading reported no remaining Genetic Technologies Ltd. position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 255 Genetic Technologies Ltd. shares in Q3 2024.
  • Simplex Trading first reported a position in Genetic Technologies Ltd. in Q4 2015 and held it in 19 quarters.
  • Simplex Trading's Genetic Technologies Ltd. position peaked at $112K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.